Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. May 27, 2025; 17(5): 107579
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.107579
Figure 1
Figure 1 Flowchart of the enrollment and matching. NACT: Neoadjuvant chemotherapy; PG: Proximal gastrectomy; TG: Total gastrectomy; PSM: Propensity score matching.
Figure 2
Figure 2 Kaplan-Meier estimates of survival stratified by surgical groups. A: With a median follow-up of 36.8 months, the 5-year overall survival rates were 52.7% for the proximal gastrectomy (PG) group and 45.5% for the total gastrectomy (TG) group; B: The 5-year recurrence-free survival rates were 54.3% and 47.6% for the PG and TG groups. PG: Proximal gastrectomy; TG: Total gastrectomy.
Figure 3
Figure 3 Forest plot of multivariate Cox regression analysis for overall survival. NACT: Neoadjuvant chemotherapy.